
UNITY is harnessing pathways of aging biology to develop new senolytic medicines, with a focus on retinal diseases | $UBX
San Francisco Bay Area, CA
Joined March 2016
- Tweets424
- Following97
- Followers5.3K
- Likes50
UNITY Biotechnology retweeted
To Reverse Aging’s Clock, Adjust the Cell’s Machinery
Epigenetic, bioelectromic, synaptic, and senolytic interventions could rejuvenate cells and counter the effects of aging.
hubs.li/Q02V-cHG0
UNITY Biotechnology retweeted
Join @UNITYBiotech $UBX on Tues, Oct. 15 at 8am ET in New York or virtually for its Ophthalmology Day for investors and analysts, featuring Robert Bhisitkul, MD, PhD, Arshad Khanani, MD, MA, FASRS, and Dante Pieramici, MD. Register: bit.ly/4gBf6rd
UNITY Biotechnology retweeted
We are thrilled to share our study on the role of cellular #senescence in #diabetic macular edema and clinical data for the first #senolytic developed for the eye . Congrats @SerCresGar and @UnityBiotech!
@UMontreal @NatureMedicine @CellSenResearch
nature.com/articles/s41591-0…
UNITY Biotechnology retweeted

Eric Topol@EricTopol6 Feb 2024
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Getting rid of old cells is a major potential anti-aging strategy. Some encouraging work using BCL-xL for diabetic retinopathy , with sight-threatening macular edema, reported today
nature.com/articles/s41591-0… @NatureMedicine @psapieha @SerCresGar @UMontreal @UnityBiotech
UNITY Biotechnology retweeted
Thank you @JulieGMD @FNIH_Org, @anirvan0419 @UnityBiotech, Reshma Rangwala @Karyopharm, Liz Thompson @Amgen, Yiannis Kiachopoulos @CausalyAI for a terrific discussion on R&D transformation #longwoodhealthcareleaders #jpm2024
UNITY Biotechnology retweeted
Every year, we pick 10 recent technological breakthroughs that we predict will have a big impact in the years to come. We're proud to release this year’s list of the technologies that we believe will make a real difference in solving important problems. technologyreview.com/lists/t…
UNITY Biotechnology retweeted
New research on dysfunctional senescent cells could help create drugs that fight against age-associated diseases in humans. fcld.ly/w11qinu #SciMagPerspective #Aging #Health
UNITY Biotechnology retweeted
Healthy #Ageing conference is great so far @ACSCevents. Great science and inspiring talks also from #biotech, including @NathanielEDavid from @UnityBiotech. Looking fwd to systems biology and omics sessions tomorrow.
UNITY Biotechnology retweeted
Best quote of the day for all of you whom think the country is lost-Doug Jones quoting MLK “The arc of the moral universe is long but it bends toward justice.” The USA is not lost...it is great..it is self-correcting from extremes on both sides of the aisle.
UNITY Biotechnology retweeted
Replying to @NathanielEDavid
UNITY Biotechnology retweeted
Love this: focus on healthspan, not lifespan, i.e. the length of healthy life.
-Ned David of @UnityBiotech. Super exciting science—and philosophy, for that matter. #SEBIO2017 – at Pinehurst, NC
UNITY Biotechnology retweeted
The Secret to Long Life? It May Lurk in the DNA of the Oldest Among Us| Article via @nytimes ow.ly/Ht7w30gy6en
UNITY Biotechnology retweeted
17 Chairmans awardee Ned David @UnityBiotech pioneering work w/ #senolytics & #healthspan featured in @nature bit.ly/2zUgQql
UNITY Biotechnology retweeted
A new episode of #RunningThroughWalls is up! This week, we chat w/ @UnityBiotech Ned David: vnrk.co/1s7JekV
UNITY Biotechnology retweeted
Popular now on Nautilus: Who says aging is inevitable? Nature doesn't. go.nautil.us/no_aging
UNITY Biotechnology retweeted
"Research on Aging Is Vital" - @NIHDirector nytimes.com/2016/05/21/opini… #agingresearch #healthspan #agebettter @nytimes
UNITY Biotechnology retweeted
Perhaps a different question: Which would want: (A) Alzheimer's, (B) cancer, (C) diabetes, (D) None of the above? xitter.cf/amy_harmon/status/7340…
Readers have mixed feelings about drug to lengthen their own healthy lives; no ambivalence about one for their dogs nytimes.com/2016/05/21/us/do…

























